Biopsychological stress factors in BRCA mutation carriers

Psychosomatics

Volumn 53, Issue 6, 2012, Pages 582-590

  Wenzel, Lari ^a,b   Osann, Kathyrn ^a,b   Lester, Jenny ^c   Kurz, Raluca ^c   Hsieh, Susie ^a,b   Nelson, Edward L ^a,b   Karlan, Beth ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; CANCER RISK; FEMALE; GENE MUTATION; HEALTH STATUS; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENTAL STRESS; QUALITY OF LIFE; SALIVA ANALYSIS;

ADULT; ANTIBIOTIC PROPHYLAXIS; BEREAVEMENT; BIOLOGICAL MARKERS; FEMALE; FOCUS GROUPS; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HETEROZYGOTE; HUMANS; HYDROCORTISONE; LINEAR MODELS; MATERNAL DEATH; MUTATION; PILOT PROJECTS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SALIVA; STRESS, PSYCHOLOGICAL;

EID: 84875411563     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2012.06.007     Document Type: Article

References (47)

1. Lerman C., Daly M., Sands C., Balshem A., Lustbader E., Heggan T., et al. Mammography adherence and Psychological distress among women at risk for breast-cancer. J Natl Cancer I 1993, 85(13):1074-1080.
2. Lerman C., Schwartz M. Adherence and psychological adjustment among women at high-risk for breast-cancer. Breast Cancer Res Tr 1993, 28:145-155.
3. Baider L., Ever-Hadani P., De-Nour A.K. Psychological distress in healthy women with familial breast cancer: like mother, like daughter?. Int J Psychiatry Med 1999, 29:411-420.
4. Erblich J., Bovbjerg D.H., Valdimarsdottir H.B. Looking forward and back: distress among women at familial risk for breast cancer. Ann Behav Med 2000, 22:53-59.
5. Valdimarsdottir H.B., Bovbjerg D.H., Kash K.M., Holland J.C., Osborne M.P., Miller D.G. Psychological distress in women with a familial risk of breast-cancer. Psychooncology 1995, 4:133-141.
6. Mosher C.E., Danoff-Burg S. Psychosocial impact of parental cancer in adulthood: A conceptual and empirical review. Clin Psychol Rev 2005, 25:365-382.
7. Kim Y., Duhamel K.N., Valdimarsdottir H.B., Bovbjerg D.H. Psychological distress among healthy women with family histories of breast cancer: effects of recent life events. Psychooncology 2005, 14:555-563.
8. Lerman C., Narod S., Schulman K., Hughes C., GomezCaminero A., Bonney G., et al. BRCA1 testing in families with hereditary breast-ovarian cancer-a prospective study of patient decision making and outcomes. J Am Med Assoc 1996, 275:1885-1892.
9. Esplen M.J., Hunter J., Leszcz M., Warner E., Narod S., Metcalfe K., et al. A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations. Cancer 2004, 101:2327-2340.
10. Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 2005, 14:1060-1074.
11. Smith A.W., Dougall A.L., Posluszny D.M., Somers T.J., Rubinstein W.S., Baum A. Psychological distress and quality of life associated with genetic testing for breast cancer risk. Psychooncology 2008, 17:767-773.
12. Hamilton R. Genetics: breast cancer as an exemplar. Nurs Clin North Am 2009, 44:327-338.
13. Lerman C., Schwartz M.D., Lin T.H., Hughes C., Narod S., Lynch H.T. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 1997, 65:414-420.
14. Baum A., Friedman A.L., Zakowski S.G. Stress and genetic testing for disease risk. Health Psychol 1997, 16:8-19.
15. Watson M., Foster C., Eeles R., Eccles D., Ashley S., Davidson R., et al. Psychosocial impact of breast/ovarian (BRCA 1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer 2004, 91:1787-1794.
16. Lobel M., Hamilton J.G., Moyer A. Emotional distress following genetic testing for hereditary breast and ovarian cancer: A meta-analytic review. Health Psychol 2009, 28:510-518.
17. Zakowski S.G., Valdimarsdottir H.B., Bovbjerg D.H., Borgen P., Holland J., Kash K., et al. Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Ann Behav Med 1997, 19:362-369.
18. Luecken L.J. Childhood attachment and loss experiences affect adult cardiovascular and cortisol function. Psychosom Med 1998, 60:765-772.
19. Krause N. Early parental loss and personal control in later life. J Gerontol 1993, 48(3):P117-P126.
20. Tyrka A.R., Wier L., Price L.H., Ross N., Anderson G.M., Wilkinson C.W., et al. Childhood parental loss and adult hypothalamic-pituitary-adrenal function. Biol Psychiatry 2008, 63:1147-1154.
21. Hoke L.A. Psychosocial adjustment in children of mothers with breast cancer. Psychooncology 2001, 10:361-369.
22. Osborn T. The psychosocial impact of parental cancer on children and adolescents: a systematic review. Psychooncology 2007, 16:101-126.
23. Stroebe M., Schut H., Stroebe W. Health outcomes of bereavement. Lancet 2007, 370:1960-1973.
24. Henderson B.J., Tyndel S., Brain K., Clements A., Bankhead C., Austoker J., et al. Factors associated with breast cancer-specific distress in younger women participating in a family history mammography screening program. Psychooncology 2008, 17:74-82.
25. Visser A., Huizinga G.A., van der Graaf W.T.A., Hoekstra H.J., Hoekstra-Weebers J.E. The impact of parental cancer on children and the family: a review of the literature. Cancer Treat Rev 2004, 30:683-694.
26. Kersting A., Kroker K. Prolonged grief as a distinct disorder, specifically affecting female health. Arch Women. Ment Health 2010, 13:27-28.
27. Luecken L.J., Appelhans B.M. Early parental loss and salivary cortisol in young adulthood: the moderating role of family environment. Dev Psychopathol 2006, 18:295-308.
28. Krause N. Early parental loss, recent life events, and changes in health among older adults. J Aging Health 1998, 10:395-421.
29. Nicolson N.A. Childhood parental loss and cortisol levels in adult men. Psychoneuroendocrinology 2004, 29:1012-1018.
30. Lachman M.E., Maier E.H. Consequences of early parental loss and separation for health and well-being in midlife. Int J Behav Dev 2000, 24:183-189.
31. Weitzner M.A., Meyers C.A., Gelke C.K., Byrne K.S., Cella D.F., Levin V.A. The Functional Assessment of Cancer-Therapy (FACT) Scale. Cancer 1995, 75:1151-1161.
32. Cohen S., Williamson G. Perceived Stress in a Probability Sample in the United States 1988, 31-67. Sage, Newbury Park, CA.
33. Horowitz M., Wilner N., Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979, 41:209-218.
34. Burnett P., Middleton W., Raphael B., Martinek N. Measuring core bereavement phenomena. Psychol Med 1997, 27:49-57.
35. Smyth M.J., Dunn G.P., Schreiber R.D. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 2006, 90:1-50.
36. Manabe I. Chronic inflammation links cardiovascular, metabolic, and renal diseases. Circ J Off J Jpn Circ Soc 2011, 75:2739-2748.
37. Schetter A.J., Heegaard N.H., Harris C.C. Inflammation and cancer: interweaving microRNA, free radical, cytokine, and p53 pathways. Carcinogenesis 2010, 31:37-49.
38. von Känel R., Bellingrath S., Kudielka B.M. Association between burnout and circulating levels of pro- and anti-inflammatory cytokines in schoolteachers. J Psychosom Res 2008, 65:51-59.
39. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., Sethi G. Inflammation and cancer: how hot is the link?. Biochem Pharmacol 2006, 72:1605-1621.
40. Johnson A.K., Grippo A.J. Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. J Physiol Pharmacol 2006, 57(Suppl 11):5-29.
41. Moore R.J., Owens D.M., Stamp G., Arnott C., Burke F., East N., et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat Med 1999, 5:828-831.
42. Arnott C.H., Scott K.A., Moore R.J., Robinson S.C., Thompson R.G., Balkwill F.R. Expression of both TNF-α receptor subtypes is essential for optimal skin tumor development. Oncogene 2004, 23:1902-1910.
43. Karabela S.P., Kairi C.A., Magkouta S., Psallidas I., Moschos C., Stathopoulos I., et al. Neutralization of tumor necrosis factor bioactivity ameliorates urethane-induced pulmonary oncogenesis in mice. Neoplasia 2011, 13:1143-1151.
44. Pappu R., Ramirez-Carrozzi V., Sambandam A. The interleukin-17 cytokine family: critical players in host defense and inflammatory diseases. Immunology 2011, 134:8-16.
45. Lutgendorf S.K., Sood A.K. Biobehavioral factors and cancer progression: physiological pathways and mechanisms. Psychosom Med 2011, 73:724-730.
46. Nelson E.L., Wenzel L.B., Osann K., Dogan-Ates A., Chantana N., Reina-Patton A., et al. Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected]. Clin Cancer Res 2008, 14:2111-2118.
47. Graves K.D., Wenzel L., Schwartz M.D., Luta G., Wileyto P., Narod S., et al. Randomized Controlled Trial of a Psychosocial Telephone Counseling Intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidem Biomar 2010, 19:648-654.